214 related articles for article (PubMed ID: 17410284)
1. Long term follow-up of a large cohort of inactive HBsAg (+)/ HBeAg (-)/ anti-HBe (+) carriers in Greece.
Gigi E; Lalla T; Orphanou E; Sinakos E; Vrettou E; Raptopoulou-Gigi M
J Gastrointestin Liver Dis; 2007 Mar; 16(1):19-22. PubMed ID: 17410284
[TBL] [Abstract][Full Text] [Related]
2. Natural history of chronic HBV infection: a cohort study with up to 12 years follow-up in North Greece (part of the Interreg I-II/EC-project).
Zacharakis GH; Koskinas J; Kotsiou S; Papoutselis M; Tzara F; Vafeiadis N; Archimandritis AJ; Papoutselis K
J Med Virol; 2005 Oct; 77(2):173-9. PubMed ID: 16121378
[TBL] [Abstract][Full Text] [Related]
3. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
Sayan M; Mutlu B; Erdoğan S; Meriç M; Willke A
Mikrobiyol Bul; 2007 Jan; 41(1):87-93. PubMed ID: 17427556
[TBL] [Abstract][Full Text] [Related]
4. [Follow-up of chronic hepatitis B carriers. Serological course and risk of reactivation].
Bujanda L; García Bengoechea M; Cilla G; Gil I; yArenas JI
Rev Esp Enferm Dig; 1996 May; 88(5):335-9. PubMed ID: 8764540
[TBL] [Abstract][Full Text] [Related]
5. Incidence and risk factors of progression to cirrhosis in inactive carriers of hepatitis B virus.
Chu CM; Liaw YF
Am J Gastroenterol; 2009 Jul; 104(7):1693-9. PubMed ID: 19455130
[TBL] [Abstract][Full Text] [Related]
6. Spontaneous loss of HBeAg and development of anti-HBe during long-term follow-up of blood donors found to be HBsAg-positive.
Brown SD; Barbara AJ; Lambert T; Wilson DV
Br J Biomed Sci; 1995 Jun; 52(2):106-9. PubMed ID: 8520247
[TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up of hepatitis B virus carriers with normal transaminases levels.
Koçak N; Ozen H; Yüce A; Gürakan F
Turk J Pediatr; 1998; 40(3):365-72. PubMed ID: 9763900
[TBL] [Abstract][Full Text] [Related]
8. The significance of spontaneous hepatitis B e antigen seroconversion in childhood: with special emphasis on the clearance of hepatitis B e antigen before 3 years of age.
Chang MH; Hsu HY; Hsu HC; Ni YH; Chen JS; Chen DS
Hepatology; 1995 Nov; 22(5):1387-92. PubMed ID: 7590652
[TBL] [Abstract][Full Text] [Related]
9. Effects of indomethacin on viral replication markers in asymptomatic carriers of hepatitis B: a randomized, placebo-controlled trial.
Bahrami H; Daryani NE; Haghpanah B; Moayyeri A; Moghadam KF; Mirmomen S; Kamangar F
Am J Gastroenterol; 2005 Apr; 100(4):856-61. PubMed ID: 15784032
[TBL] [Abstract][Full Text] [Related]
10. The role of serial measurement of serum HBV DNA levels in patients with chronic HBeAg(-) hepatitis B infection: association with liver disease progression. A prospective cohort study.
Zacharakis G; Koskinas J; Kotsiou S; Tzara F; Vafeiadis N; Papoutselis M; Maltezos E; Sivridis E; Papoutselis K
J Hepatol; 2008 Dec; 49(6):884-91. PubMed ID: 18674840
[TBL] [Abstract][Full Text] [Related]
11. An evaluation of transient elastography in the discrimination of HBeAg-negative disease from inactive hepatitis B carriers.
Maimone S; Calvaruso V; Pleguezuelo M; Squadrito G; Amaddeo G; Jacobs M; Khanna P; Raimondo G; Dusheiko G
J Viral Hepat; 2009 Nov; 16(11):769-74. PubMed ID: 19709363
[TBL] [Abstract][Full Text] [Related]
12. Response to interferon-alpha in chronic hepatitis B patients with and without precore mutant strain and effects on HBsAg titers.
Akhan SC; Yulugkural Z; Vahaboglu H
Chemotherapy; 2007; 53(6):402-6. PubMed ID: 17934260
[TBL] [Abstract][Full Text] [Related]
13. Determination of serum hepatitis B virus DNA in chronic HBsAg carriers: clinical significance and correlation with serological markers.
Yalçin K; Değertekin H; Alp MN; Tekeş S; Satici O; Budak T
Turk J Gastroenterol; 2003 Sep; 14(3):157-63. PubMed ID: 14655057
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcome after hepatitis B surface antigen seroclearance in patients with chronic hepatitis B.
Arase Y; Ikeda K; Suzuki F; Suzuki Y; Saitoh S; Kobayashi M; Akuta N; Someya T; Hosaka T; Sezaki H; Kobayashi M; Kumada H
Am J Med; 2006 Jan; 119(1):71.e9-16. PubMed ID: 16431195
[TBL] [Abstract][Full Text] [Related]
15. Natural history of chronic hepatitis B virus infection in children of different ethnic origins: a cohort study with up to 12 years' follow-up in northern Greece.
Zacharakis G; Koskinas J; Kotsiou S; Pouliou E; Papoutselis M; Tzara F; Vafeiadis N; Maltezos E; Archimandritis A; Papoutselis K
J Pediatr Gastroenterol Nutr; 2007 Jan; 44(1):84-91. PubMed ID: 17204959
[TBL] [Abstract][Full Text] [Related]
16. Liver function and hepatitis markers in carriers of hepatitis B virus in New Zealand.
Hopkirk N; Moyes CD; Lucas CR
N Z Med J; 2000 Apr; 113(1107):114-6. PubMed ID: 10834277
[TBL] [Abstract][Full Text] [Related]
17. [Clinical significance of HBeAg and anti-HBe in HBsAg positive liver diseases].
Takahashi A; Sekiya C; Yazaki Y; Tominaga Y; Oohara K; Ono M; Sato H; Hasebe C; Namiki M
Hokkaido Igaku Zasshi; 1983 Jan; 58(1):30-42. PubMed ID: 6840666
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.
Fwu CW; Chien YC; Kirk GD; Nelson KE; You SL; Kuo HS; Feinleib M; Chen CJ
J Natl Cancer Inst; 2009 Jul; 101(14):1019-27. PubMed ID: 19535774
[TBL] [Abstract][Full Text] [Related]
19. Chronic hepatitis B virus carriers in the immunotolerant phase of infection: histologic findings and outcome.
Andreani T; Serfaty L; Mohand D; Dernaika S; Wendum D; Chazouillères O; Poupon R
Clin Gastroenterol Hepatol; 2007 May; 5(5):636-41. PubMed ID: 17428739
[TBL] [Abstract][Full Text] [Related]
20. Chronic hepatitis B in children after e antigen seroclearance: final report of a 29-year longitudinal study.
Bortolotti F; Guido M; Bartolacci S; Cadrobbi P; Crivellaro C; Noventa F; Morsica G; Moriondo M; Gatta A
Hepatology; 2006 Mar; 43(3):556-62. PubMed ID: 16496323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
